首页> 外文OA文献 >The Effectiveness and Safety of Triple-Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta-Analysis

【2h】

The Effectiveness and Safety of Triple-Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta-Analysis

机译：基于皮洛司唑治疗患者经皮冠状动脉介入的患者的效果和安全性：META分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ping Wang; Shijie Zhou; Rui Zhou; Gan Liu; Ping Tang; Jing He; Cong Ma; Yi He; Jinliang Yang;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The effectiveness and safety of triple-antiplatelet treatment based on cilostazol for patients receiving percutaneous coronary intervention: A meta-analysis [J] . WangP., ZhouS., ZhouR., Clinical cardiology. . 2012,第10期

机译：基于西洛他唑的三联抗血小板治疗对经皮冠状动脉介入治疗患者的有效性和安全性：一项荟萃分析
2. The Effectiveness and Safety of Triple-Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta-Analysis [J] . Ping Wang MS, Shijie Zhou MS, Rui Zhou PhD, Clinical cardiology. . 2012,第10期

机译：基于西洛他唑的三联抗血小板治疗接受经皮冠状动脉介入治疗的有效性和安全性：一项荟萃分析
3. Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention [J] . Mei Wang, Guoru Zhang, Yaling Wang, Therapeutics and Clinical Risk Management . 2015,第2期

机译：比伐卢定加西洛他唑基三联抗血小板负荷剂量治疗经皮冠状动脉介入治疗后非ST段抬高型心肌梗死
4. Effectiveness of the integration of different types of quantitative and qualitative assessment indicators for the patients with ischemic heart disease who underwent percutaneous coronary intervention (PCI) [C] . Yasuhara Yuko, Harano Kaori, Fujikawa Eiji, 7th International Conference on Natural Language Processing and Knowledge Engineering . 2011

机译：整合不同类型的定量和定性评估指标对接受经皮冠状动脉介入治疗（PCI）的缺血性心脏病患者的有效性
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. The Effectiveness and Safety of Triple‐Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta‐Analysis [O] . Ping Wang, Shijie Zhou, Rui Zhou, 2012

机译：基于西洛他唑的三联抗血小板治疗在接受经皮冠状动脉介入治疗的患者中的有效性和安全性：一项荟萃分析
7. Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention [O] . Yongjun Li, Mei Wang, Guoru Zhang, 2015

机译：Bivalirudin加载基于西洛司唑类的三重抗血小板，治疗经皮冠状动脉介入后的非ST-EXTATION心肌梗死
8. Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease. Executive Summary. Effective Health Care Program Research Report No. 9 [R] . 2007

机译：经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗冠心病的疗效比较。执行摘要。有效的医疗保健计划研究报告第9号

The Effectiveness and Safety of Triple-Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta-Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅